We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

281 hedge funds and large institutions have $3.8B invested in Nektar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 90 increasing their positions, 96 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $3.24B → $3.8B (+$553M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 61

0.11% less ownership

Funds ownership: 6.77% → 6.67% (-0.11%)

6% less repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 96

2% less funds holding

Funds holding: 288 → 281 (-7)

16% less call options, than puts

Call options by funds: $36.1M | Put options by funds: $42.8M

Holders
281
Holders Change
-7
Holders Change %
-2.43%
% of All Funds
5.54%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
61
Increased
90
Reduced
96
Closed
61
Calls
$36.1M
Puts
$42.8M
Net Calls
-$6.64M
Net Calls Change
-$6.54M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$93.9M
2
MC
Maverick Capital
Texas
+$62.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$35M
4
Primecap Management
Primecap Management
California
+$18.5M
5
CCM
Camber Capital Management
Massachusetts
+$14.5M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$58.3M
2
State Street
State Street
Massachusetts
-$55.5M
3
GPP
Great Point Partners
Connecticut
-$38.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$32.3M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$15M
Name Holding Trade Value Shares
Change 		Change in
Stake
S
326
Seeyond
France
– -$114K -418 Closed
LWM
327
Liberty Wealth Management
California
– -$55.4K -191 Closed
O
328
Ossiam
France
– -$40K -145 Closed
RIM
329
Rampart Investment Management
Connecticut
– -$36K -130 Closed
IUHSA
330
Itau Unibanco Holding S.A.
Brazil
– -$62K -117 Closed
LS
331
Livforsakringsbolaget Skandia
Sweden
– -$27K -100 Closed
CIAS
332
Capital Investment Advisory Services
North Carolina
– -$15K -53 Closed
GLI
333
Guardian Life Insurance
New York
– -$9K -34 Closed
AIM
334
AIA Investment Management
Singapore
– -$5K -20 Closed
Bessemer Group
335
Bessemer Group
New Jersey
– -$3K -11 Closed
SLF
336
Sun Life Financial
Ontario, Canada
– -$3K -10 Closed
FMII
337
Farmers & Merchants Investments Inc
Nebraska
– -$2K -6 Closed
ZB
338
Zions Bancorporation
Utah
– -$1K -4 Closed
OSAM
339
O'Shaughnessy Asset Management
Connecticut
– +$290 +1 New
10 11 12 13
14

NKTR Hedge Fund Activity: Q4 2019 in Review

281 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q4 2019, worth a combined $3.8B — up 17% from $3.24B a quarter earlier.

Fund positioning in NKTR was balanced in Q4 2019: 61 funds opened new positions, 61 closed out, 90 added to existing stakes and 96 trimmed.

The largest buyer was BlackRock, adding an estimated $93.9M. The largest seller was Invesco, cutting an estimated $58.3M.

  • 281 institutional investors held Nektar Therapeutics (NKTR) as of Q4 2019, down from 288 in Q3 2019.
  • Funds reported $3.8B of Nektar Therapeutics stock for Q4 2019, up 17% quarter-over-quarter.
  • 61 funds opened new Nektar Therapeutics positions in Q4 2019 and 61 closed out, a net change of 0 holders.
  • The largest Nektar Therapeutics buyer in Q4 2019 was BlackRock, an estimated $93.9M added.
  • The largest Nektar Therapeutics seller in Q4 2019 was Invesco, an estimated $58.3M sold.

Based on aggregated 13F filings for Q4 2019.